Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,576,906
-
Share change
-
-637,240
-
Total reported value
-
$301,501,000
-
Price per share
-
$11.79
-
Number of holders
-
46
-
Value change
-
-$15,335,690
-
Number of buys
-
23
-
Number of sells
-
15
Institutional Holders of Jade Biosciences, Inc. - COM (AVTE) as of Q4 2021
As of 31 Dec 2021 Jade Biosciences, Inc. - COM (AVTE) had 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 25,576,906 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Sofinnova Investments, Inc., Atlas Venture Life Science Advisors, LLC, BAKER BROS. ADVISORS LP, Cormorant Asset Management, LP, CITADEL ADVISORS LLC, TCG Crossover Management, LLC, BlackRock Inc., FMR LLC, and OUP Management Co., LLC.
This table shows 46 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.